Latest filing published 05 Jun 2026 for Sarepta Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -38.0%Entry US$38.16 · Close at T+365 US$23.66
- -10.7%Entry US$69.75 · Close at T+365 US$62.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Deirdre P. Connelly: trading record in brief
Deirdre P. Connelly has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Macy's, Inc., ELI LILLY & Co and Sarepta Therapeutics, Inc. Over a trading history stretching from 20 January 2006 to 4 June 2026, the count stands at 28 filings.
Market trades split into 2 purchases (€164k) and 6 sales (€446k). Taken together, the sales exceed the purchases by €281k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 9 share grants and 11 option exercises.
The latest filing, published on 5 June 2026, reports a share grant in Sarepta Therapeutics, Inc. The last insider purchase was made public on 18 November 2022, 1,452 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Deirdre P. Connelly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,875 sharesCommon StockSEC:0001193125-26-260255:0
- 2,383 sharesCommon StockSEC:0000950170-25-037533:0
- 2,842 shares0Common StockSEC:0000950170-24-106954:0
- 3,000 shares@ US$37.41100.0% of flowCommon StockSEC:0001214659-22-014003:0Canonical exit: 16 Feb 2023 (T+90)
- 10,000 shares@ US$11.3241.3% of flowCommon StockSEC:0000794367-19-000040:0
- 6,250 shares@ US$25.7658.7% of flowCommon StockSEC:0000794367-19-000040:1
- 1,000 shares@ US$67.0934.1% of flowCommon StockSEC:0001214659-18-003948:0Canonical exit: 2 Aug 2018 (T+90)
- 2,100 shares@ US$29.257.5% of flowCommon StockSEC:0000794367-18-000022:3
- 1,222 shares@ US$29.264.3% of flowCommon StockSEC:0000794367-18-000022:4
- 10,000 shares@ US$25.3230.8% of flowCommon StockSEC:0000794367-18-000022:0
- 5,178 shares@ US$29.2518.4% of flowCommon StockSEC:0000794367-18-000022:1
- 592 shares@ US$29.252.1% of flowCommon StockSEC:0000794367-18-000022:2
- 622 shares0Common StockSEC:0000794367-13-000002:0
- 742 shares0Common StockSEC:0000794367-12-000164:0
- 824 shares0Common StockSEC:0000794367-12-000138:0
- 1,486 shares0Common StockSEC:0000794367-12-000100:0
- 1,060 shares0Common StockSEC:0000794367-12-000002:0
- 468 shares0Common StockSEC:0000794367-11-000139:0
- 435 shares0Common StockSEC:0000794367-11-000122:0
- 547 shares0Common StockSEC:0000794367-11-000063:0
- 6,432 shares@ US$51.52Common StockSEC:0001209191-08-007711:0
- 26,276 shares@ US$50.74Common StockSEC:0001209191-08-006202:0
- 3,925 shares@ US$54.12Common StockSEC:0001209191-07-007668:0
- 2,141 shares@ US$54.12Common StockSEC:0001209191-06-065470:0
- 2,800 shares@ US$34.60Common StockSEC:0001209191-06-045145:0
25 of 27 declarations
